Across TCGA pan-cancer cohorts, RNU6-983P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-983P data layer.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU6-983P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-983P expression acts as an unfavorable survival marker.
KIRC are the cancer types where RNU6-983P RNA most reproducibly stratifies survival.